Illustration: This is in Bandra again, in a slum. This is a drug-resistant TB patient with HIV as well. He was happy to have us there and let us draw him and talk to him, and the stigma wasn’t an issue for him. This is really a description of the outside of the house where he lives with his mum and his other brother. She’s raised six children here; he sleeps outside as a sort of precaution, she sleeps inside, and this is his bed which is covered up by bits of plastic bags and propped up by pillars and corrugated iron. It gives you an idea of the sort of places that [MSF’s patients] are living in, and living in when they’ve got this horrible disease. India 2013 © George Butler
MSF’s HIV/TB Project in Mumbai
MSF invited illustrator George Butler to visit our HIV and MDR-TB project in Mumbai, India to capture our activities there. He returned with images and stories of families affected by multidrug-resistant TB, their care givers, and the MSF team responsible for their treatment.
Illustration: India 2013 © George Butler
MSF’s HIV/TB Project in Mumbai
MSF invited illustrator George Butler to visit our HIV and MDR-TB project in Mumbai, India to capture our activities there. He returned with images and stories of families affected by multidrug-resistant TB, their care givers, and the MSF team responsible for their treatment.

59 plays
NPR reports on this week’s landmark ruling by India’s Supreme Court that means Indian generic drug manufacturers can keep producing affordable medicines for use in developing countries. Learn more about drug patents.
Photo: Hundreds of activists gathered in New Delhi to protest Novartis’s attack on India’s patent laws in 2007. MSF and others continue to oppose the legal case today. India 2007 © MSF
The Novartis Drop the Case Campaign
Yesterday, India’s Supreme Court upheld India’s Patent Act in the face of a seven-year challenge by Swiss pharmaceutical company Novartis.
“This is a huge relief for the millions of patients and doctors in developing countries who depend on affordable medicines from India, and for treatment providers like MSF,” said Dr. Unni Karunakara, MSF’s international president.
BREAKING NEWS
Novartis has lost its case in Indian Supreme Court today, protecting access to affordable, quality medicines for people in developing countries.
Rape is a crime that affects many aspects of human life; it is a medical emergency, it is a psychological trauma and it has deep consequences on both family and societal level. It is of utmost importance that survivors of rape have access to immediate medical and psychological care, and also for the sake of preventing sexual violence altogether in a long-term perspective it is important that women’s rights in general are improved.
The day-to-day purpose of the project here is to heal kids like George of their severe acute malnutrition, so that they avoid stunting or, worse, death, and you could no more quantify this benefit than you could put a price on a human life. But MSF is here with an additional, even more ambitious goal: if we can help kids like George with a model of community based nutritional care tailor-made specifically for the Bihar State, India setting, then we might just be able to convince the government to adopt this model of care, scale it up and then help every sick kid like George.
But can you ‘treat’ malnutrition? Maybe there is something strange about putting illnesses which are directly caused by very specific parasites in the same bracket as one with “geosociopolitical” causes. The facts are plain though. Whether you choose to label it as a disease or not (and MSF does), you can do something about it, and that is what really matters.
MSF Launches Online Resource To Combat Unwarranted Drug Patent Requests
There are many reasons why people lack access to essential medicines, but one of the major barriers is the high price of drugs. Patents prevent the open competition that could drive prices down to lower, affordable levels. MSF Access Campaign launched an online database to help groups challenge unfair drug patents. Don’t give up. Keep up the fight!
Photo: Protesters carry signs outside Novartis’s Mumbai office on Worlds AIDS Day. India 2011 © Claudio Tommasini
Leena Menghaney: India’s Patent Law on Trial
In this piece from BMJ Group Blogs, lawyer and India manager of MSF’s Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India’s medicines patent law. Learn more at www.msfaccess.org
This decision once again affirms that courts can and should act in the interest of public health in the case of pharmaceutical products.
Indian court case crucial for cancer sufferers
India’s Supreme Court heard arguments this week in a long-running legal case about drug patents. Swiss drug maker Novartis is fighting for exclusive rights to produce its blockbuster cancer drug, Gleevec. If it wins, that will change the rules for generic drugmakers who supply millions of poorer patients in India and elsewhere. It’s also sparked a wider debate about the affordability of life-saving drugs.
Listen to the report from American Public Media’s Marketplace.
Photo: A child suffering from cancer in New Delhi, India. Sajjad Hussain/AFP/Getty Images
Young or old, no one should have to face this uphill struggle, due to a simple lack of nutrition.
Luke writes with tenderness about the tragic case of Reena, a malnourished four-year-old girl, who despite best efforts, fails to survive.
Luke is a pediatrician working in Biraul, India.
Novartis: the world is watching you, and we are not standing by silently. #STOPnovartis
Take action: http://www.msfaccess.org/STOPnovartis